Sestrin2 Suppression and Endothelial Dysfunction
Author Information
Author(s): Abdelsalam Shahenda Salah, Zahid Muhammad Ammar, Ghanem Sarah Khalaf, Khan Abbas, Parray Aijaz, Agouni Abdelali
Primary Institution: Department of Pharmaceutical Sciences, College of Pharmacy, QU Health, Qatar University
Hypothesis
The suppression of SESN2 promotes the process of EndMT and exacerbates the detrimental effects of MGO on inducing EndMT, contributing to diabetic vascular complications.
Conclusion
SESN2 plays a critical protective role in endothelial cells against MGO-induced damage, and its downregulation may contribute to the pathogenesis of diabetic vascular complications.
Supporting Evidence
- SESN2 knockdown significantly exacerbated MGO-induced oxidative stress.
- SESN2 silencing enhanced the inflammatory response to MGO.
- SESN2 deficiency promoted EndMT, increasing mesenchymal markers and decreasing endothelial markers.
Takeaway
When a protein called SESN2 is turned off in blood vessel cells, it makes those cells more likely to change into a different type of cell that can cause problems in diabetes.
Methodology
Human endothelial cells were transfected with SESN2 siRNA to silence SESN2 expression, followed by treatment with methylglyoxal (MGO) to study its effects on oxidative stress and inflammatory responses.
Limitations
The study primarily uses an in vitro model, which may not fully replicate in vivo conditions, and the acute exposure to MGO may not represent chronic hyperglycemia.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website